title: Targeting RV failure and cardiomyocyte injury in acute pulmonary thromboembolism.
authors: Department of Pharmacology, Ribeirao Preto School of Medicine, University of Sao Paulo, Avenida dos Bandeirantes, 3900, 14049-900 Ribeirao Preto, Sao Paulo, Brazil tanus@fmrp.usp.br.
authors: Jose E
authors: JE
authors: Tanus-Santos
mesh_terms: D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D018497:Ventricular Dysfunction, Right / Q000175:diagnosis* / Q000628:therapy*; D016278:Ventricular Function, Right
references: Int J Cardiol. 2007 Jan 2;114(1):22-7
references: 16650492
references: Clin Chim Acta. 2008 Feb;388(1-2):184-8
references: 18047836
references: Naunyn Schmiedebergs Arch Pharmacol. 2012 Jul;385(7):685-96
references: 22552729
references: Cardiovasc Drugs Ther. 2013 Aug;27(4):259-67
references: 23568586
references: Crit Care Med. 2007 Jan;35(1):239-45
references: 17133179
references: Heart. 2011 Oct;97(20):1695-9
references: 21791512
references: Crit Care Med. 2011 Feb;39(2):349-56
references: 20890187
references: Curr Drug Targets. 2013 Mar;14(3):344-52
references: 23316966
references: Nitric Oxide. 2005 Feb;12(1):9-14
references: 15631942
references: Nat Rev Cardiol. 2013 Apr;10(4):204-18
references: 23399974